Surgical Science (Sweden) Today
| SUS Stock | SEK 133.00 4.70 3.41% |
PerformanceVery Weak
| Odds Of DistressLow
|
Surgical Science is selling for under 133.00 as of the 23rd of March 2025; that is 3.41 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 131.8. Surgical Science has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Surgical Science Sweden AB develops and markets virtual reality simulators for evidence based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on Stockholm Stock Exchange in Sweden.. The company has 50.8 M outstanding shares. More on Surgical Science Sweden
Moving together with Surgical Stock
Moving against Surgical Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Surgical Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Surgical Science's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Surgical Science or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Information Services, Technology (View all Sectors) |
Surgical Science Sweden (SUS) is traded on Stockholm Exchange in Sweden and employs 233 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Surgical Science's market, we take the total number of its shares issued and multiply it by Surgical Science's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Surgical Science Sweden operates under Technology sector and is part of Health Information Services industry. The entity has 50.8 M outstanding shares.
Surgical Science Sweden has accumulated about 316.68 M in cash with 39.08 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.15.
Check Surgical Science Probability Of Bankruptcy
Ownership AllocationSurgical Science Sweden shows a total of 50.8 Million outstanding shares. Over half of Surgical Science's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Surgical Science Sweden. Please watch out for any change in the institutional holdings of Surgical Science as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Surgical Ownership Details
Surgical Science Sweden Risk Profiles
Although Surgical Science's alpha and beta are two of the key measurements used to evaluate Surgical Science's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.97 | |||
| Standard Deviation | 3.41 | |||
| Variance | 11.63 | |||
| Risk Adjusted Performance | (0.03) |
Surgical Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Surgical Science without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Surgical Science Corporate Management
Elected by the shareholders, the Surgical Science's board of directors comprises two types of representatives: Surgical Science inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Surgical. The board's role is to monitor Surgical Science's management team and ensure that shareholders' interests are well served. Surgical Science's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Surgical Science's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Inbal MazorBadichi | VP Marketing | Profile | |
| Ran Bronstein | Pres RD | Profile | |
| Anna Ahlberg | Chief Officer | Profile | |
| Adv | Chief Officer | Profile | |
| Daniel Evestedt | Head Devel | Profile | |
| Jeffrey Berkley | Chief Officer | Profile | |
| Martin Jansson | Head Sales | Profile |
Additional Tools for Surgical Stock Analysis
When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.